G. Raggi1, Lea de Maddalena1, Laurène Froment1, Nicole Albrecher1, Arunima Sengupta2,3, Andreas Hugi1, Léa Todeschini1, Janick D. Stucki1, and Nina Hobi1
1AlveoliX AG, Swiss Organs-on-Chip Innovation, Bern (Switzerland)
2Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering, University of Bern (Switzerland)
3 Alexis Technologies AG, Bern (Switzerland)
This poster shows the predictive capabilities of the AXLung-on-chip System for inhalation toxicology studies within physiological conditions, drug safety (TCB) and efficacy testing (NTD) and identification of therapeutic targets (Heme-injury model).
